• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library

    Celgene Corp`s Reblozyl® (luspatercept-aamt) Receives Suppl Approval in US

    FDA

    Celgene Corp`s Reblozyl® (luspatercept-aamt) Receives Approval in US

    FDA

    Celgene Europe`s Abecma (idecabtagene vicleucel) Receives Approval in Europe

    EMA

    Celgene Europe BV Generic Reblozyl (Luspatercept) Receives Approval in Europe

    EMA

    Celgene Europe BV Generic Zeposia (ozanimod)Receives Approval in Europe

    EMA

    Celgene`s Reblozyl (luspatercept-aamt) Receives Supplemental Approval in US

    FDA

    Celgene`s Reblozyl (luspatercept-aamt) Receives Supplemental Approval in US

    FDA

    Celgene`s REBLOZYL (luspatercept-aamt) Receives Supplemental Approval in US

    FDA

    Novartis snags EU approval for multiple myeloma med Farydak

    FIERCE PHARMA

    Celgene`s Pomalyst (Pomalidomide) Receives Supplemental Approval in USA For Multiple Myeloma

    FDA

    Celgene`s OTEZLA (Apremilast) Approved in Europe for Psoriasis and Psoriatic Arthritis

    EMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.